Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209381

PLENVU (ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE)
7.54GM;140GM;2.2GM;48.11GM;5.2GM;9GM Marketing Status: Prescription

Active Ingredient: ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
Proprietary Name: PLENVU
Dosage Form; Route of Administration: FOR SOLUTION; ORAL
Strength: 7.54GM;140GM;2.2GM;48.11GM;5.2GM;9GM
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209381
Product Number: 001
Approval Date: May 4, 2018
Applicant Holder Full Name: SALIX PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English